The Enterprise Value as of June 2026 (TTM) for Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) is 11.03M

According to Cuprina Holdings (Cayman) Limited Class A Ordinary Shares’s latest financial reports and current stock price. The company's current Enterprise Value is 11.03M. This represents a change of -791.80% compared to the average of -1594625.25 of the last 4 quarters.

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) Historical Enterprise Value (quarterly & annually)

How has CUPR Enterprise Value performed in the past?

The mean historical Enterprise Value of Cuprina Holdings (Cayman) Limited Class A Ordinary Shares over the last ten years is 95.65M. The current 11.03M Enterprise Value has changed 1.05% with respect to the historical average. Over the past ten years (40 quarters), CUPR's Enterprise Value was at its highest in in the December 2024 quarter at 138.32K. The Enterprise Value was at its lowest in in the June 2025 quarter at -3898718.00.

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Cuprina Holdings (Cayman) Limited Class A Ordinary Shares Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) Average Enterprise Value

How has CUPR Enterprise Value performed in the past?

The current Enterprise Value of Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) Enterprise Value vs. Peers

How is CUPR’s Enterprise Value compared to its peers?

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares’s Enterprise Value is greater than Curis, Inc. (-8118049.00), less than Hoth Therapeutics, Inc. (20.84M), greater than Processa Pharmaceuticals, Inc. (3.23M), less than Palisade Bio, Inc. (164.19M), greater than BriaCell Therapeutics Corp. (-1764959.85), greater than Curanex Pharmaceuticals Inc Common Stock (5.39M), greater than Synlogic, Inc. (-5449486.00), greater than Pulmatrix, Inc. (1.79M), greater than Aspire Biopharma Holdings, Inc. (-4785565.00), less than Entero Therapeutics, Inc. (19.92M),

Build a custom stock screener for Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cuprina Holdings (Cayman) Limited Class A Ordinary Shares using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cuprina Holdings (Cayman) Limited Class A Ordinary Shares or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.